2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
2
Sarcoma, Ewing
1
Osteoporotic Fractures
1
Osteoporosis
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Musculoskeletal Pain
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Arthralgia
1
Interventions
Cyclophosphamide
25
Temozolomide
22
Vincristine
18
Irinotecan
18
Doxorubicin
13
Topotecan
10
Melphalan
10
Etoposide
10
Ifosfamide
8
Busulfan
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
Granulocyte Colony-Stimulating Factor
7
Filgrastim
6
regorafenib
5
fludarabine
5
X-Rays
5
Specimen Handling
5
Sirolimus
5
Radiotherapy
5
Gemcitabine
5
Drug Therapy
5
pegfilgrastim
4
palbociclib
4
liposomal doxorubicin
4
irinotecan sucrosofate
4
ganitumab
4
fludarabine phosphate
4
Trabectedin
4
Phantoms, Imaging
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Diphosphonates
×
Clear all
NCT00987636
2019-10-22
EWING2008
University Hospital Muenster
Phase 3
Completed
907 enrolled